CanSino, a Chinese anticovid vaccine endorsed for emergency use by the WHO

CanSino the first vaccine of the year endorsed and incorporated into the list of vaccines approved for emergency use by the World Health Organization (WHO). With an efficacy of 92 percent against serious reactions of the virus and compliance with all standards during the inspection of the manufacturing laboratory, demonstrated that the vaccine outweighs the risks posed by COVID-19. The WHO Emergency List assesses the quality, safety, and efficacy of influenza vaccines. COVID-19 as a prerequisite for the supply of these, once approved, it allows countries to accelerate their own regulatory approval to import and administer vaccines. The objective of…